0000000000408700
AUTHOR
Kārlis-agris Gross
Formation of nanosized strontium substituted hydroxyapatites
Incorporation of specific elements into calcium phosphates offers the combination of a bioactive material and a therapeutic effect. This is important for improving the integration of implants as well as treating medical conditions. Strontium is a suitable candidate and displays the ability to stimulate bone growth and reducing bone resorption. This study investigated the formation of strontium carbonated hydroxyapatite nanoparticles from an amorphous phase. Crystallization of carbonated hydroxyapatite occurred at 585 o C, but samples with an intended 25% and 75% replacement of calcium with strontium crystallized at 624 o C. Heat treatment at the crystallization temperature revealed that str…
Traversing Phase Fields towards Nanosized Beta Tricalcium Phosphate
The difficulty of beta tricalcium phosphate (β-TCP) crystallization in aqueous media opens the question whether β-TCP can be produced using an alternative pathway. Amorphous calcium phosphate (ACP) is metastable in an aqueous environment and prefers a more stable apatite phase. Others have transformed a crystallized calcium deficient hydroxyapatite (Ca-def HAp) into β-TCP, but automatic transformation from ACP to Ca-def HAp followed by transformation to β-TCP has not been addressed. This work shows the formation of Ca-def HAp after different aging times of ACP and the subsequent transition to β-TCP. An amorphous phase with a Ca/P ratio of 1.5 was synthesized, rinsed, filtered and excess flu…